scispace - formally typeset
M

Masaaki Nakayama

Researcher at Tohoku University

Publications -  245
Citations -  8900

Masaaki Nakayama is an academic researcher from Tohoku University. The author has contributed to research in topics: Peritoneal dialysis & Kidney disease. The author has an hindex of 40, co-authored 236 publications receiving 7811 citations. Previous affiliations of Masaaki Nakayama include Fukushima University & International University, Cambodia.

Papers
More filters
Journal Article

Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: An analysis based on changes in peritoneal function during and after CAPD withdrawal

Masaaki Nakayama, +11 more
- 01 May 2002 - 
TL;DR: It is indicated that PET has clinical relevance in examining sequential changes in peritoneal function and in detecting those patients at risk of EPS.
Journal ArticleDOI

Boucher-Neuhauser syndrome associated with hypocalciuric hypercalcemia.

Mayuri Ichinose, +5 more
- 01 Jan 1995 - 
TL;DR: In this article, a 52-year-old woman was diagnosed as having cerebellar ataxia, hypogonadotropic hypogono-morphosis and retinochoroidal degeneration, the so-called Boucher-Neuhauser syndrome.
Journal ArticleDOI

Transluminal replacement of displaced peritoneal catheter using a special "alpha-replacer" guidewire: effectiveness and limitations.

Hiroyuki Terawaki, +7 more
- 01 Nov 2007 - 
TL;DR: TRC using the alpha-replacer as described herein offers effective and safe treatment of peritoneal catheter displacement and might improve the effectiveness of TRC.
Journal ArticleDOI

Hypertrophic cranial pachymeningitis in mpo-anca-related vasculitis: a case report and literature review

Kimio Watanabe, +8 more
- 01 Jan 2013 - 
TL;DR: HCP is an important complication in MPO-ANCA-related vasculitis, and needs to be considered during the clinical course, according to a 75-year-old woman with rapidly progressive glomerulonephritis.

Sodium sulfite and N-acetylcysteine: new additives to dialysate for inhibiting formation of glucose degradation products and advanced glycation end-products.

Asahi Sakai, +4 more
TL;DR: It is believed that 6 chemicals may effectively quench GDPs and inhibit AGE cross-link formation, in a manner different from that of aminoguanidine and thiazolium.